Literature DB >> 11259810

Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease.

F Paganelli1, J M Maixent, M J Duran, R Parhizgar, G Pieroni, S Sennoune.   

Abstract

A low frequency of ischaemic heart diseases in Eskimos has been related to polyunsaturated fatty acids. We therefore studied fatty acid patterns associated with coronary artery disease (CAD) for a possible relationship between fatty acid profile and CAD diagnosis in Mediterranean patients. The gas chromatography method was used to analyze the membranes of patients' erythrocytes. The patients without coronary stenosis were used as controls. Patients with CAD showed increased percentages of saturated fatty acids (35.8 vs. 34.2%, P<0.001) and monounsaturated fatty acids (14.6 vs. 13.6%, P<0.01), as well as reduced percentages of polyunsaturated fatty acids (38.5 vs. 41.3%, P<0.001). The decrease in polyunsaturated fatty acids percentages was due to the series of n-3 fatty acids (9.2 vs. 11.4%, P<0.001), mainly at the expense of docosahexaenoic acid [C22:6 (n-3)] (4.9+/-0.25% vs. 6.4+/-0.23%, P<0.001) and docosapentaenoic acid [C22:5 (n-3)] (3.0+/-0.19% vs. 3.9+/-0.12%, P<0.001). The study shows altered n-3 fatty acids in Mediterranean patients with CAD. Our data suggest that the percentage of docosahexaenoic and docosapentaenoic acids in erythrocytes could be used as indicators of an independent risk factor for coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259810     DOI: 10.1016/s0167-5273(00)00442-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.

Authors:  Wei Jiang; Harry Oken; Mona Fiuzat; Linda K Shaw; Carolyn Martsberger; Maragatha Kuchibhatla; Rima Kaddurah-Daouk; David C Steffens; Rebecca Baillie; Michael Cuffe; Ranga Krishnan; Christopher O'Connor
Journal:  J Cardiovasc Transl Res       Date:  2011-11-01       Impact factor: 4.132

2.  Trans fatty acids and atopic eczema/dermatitis syndrome: the relationship with a free radical cis-trans isomerization of membrane lipids.

Authors:  Carla Ferreri; Federica Angelini; Chryssostomos Chatgilialoglu; Sergio Dellonte; Viviana Moschese; Paolo Rossi; Loredana Chini
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

3.  Maternal and umbilical cord erythrocyte omega-3 and omega-6 fatty acids and haemorheology in singleton and twin pregnancies.

Authors:  M McFadyen; J Farquharson; F Cockburn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

4.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

5.  Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids.

Authors:  Delia Di Stasi; Roberto Bernasconi; Roberto Marchioli; Rosa Maria Marfisi; Giovanna Rossi; Gianni Tognoni; Maria Teresa Tacconi
Journal:  Eur J Clin Pharmacol       Date:  2004-04-07       Impact factor: 2.953

Review 6.  Cardioprotective effects of ω -3 PUFAs in chronic kidney disease.

Authors:  Su Mi Lee; Won Suk An
Journal:  Biomed Res Int       Date:  2013-04-04       Impact factor: 3.411

7.  Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy.

Authors:  Su Mi Lee; Seuk Hee Chung; Yongjin Park; Mi Kyoung Park; Young Ki Son; Seong Eun Kim; Won Suk An
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

Review 8.  A review of the biologic and pharmacologic role of docosapentaenoic acid n-3.

Authors:  Puya G Yazdi
Journal:  F1000Res       Date:  2013-11-25

9.  The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study.

Authors:  Su Mi Lee; Young Ki Son; Seong Eun Kim; Won Suk An
Journal:  Mar Drugs       Date:  2015-01-28       Impact factor: 5.118

10.  Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil.

Authors:  Vanu R Ramprasath; Inbal Eyal; Sigalit Zchut; Peter J H Jones
Journal:  Lipids Health Dis       Date:  2013-12-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.